Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
13.24
+0.10 (0.76%)
At close: Apr 20, 2026, 4:00 PM EDT
13.17
-0.07 (-0.53%)
After-hours: Apr 20, 2026, 4:00 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $133.82 million as of April 20, 2026. Its market cap has increased by 46.04% in one year.
Market Cap
133.82M
Enterprise Value
189.76M
1-Year Change
46.04%
Ranking
Category
Stock Price
$13.24
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $133.82M, a decrease of -60.21%. That is a compound annual growth rate of -15.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 132.81M | 145.49% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Castle Biosciences | 758.91M |
| Personalis | 704.48M |
| Myriad Genetics | 475.02M |
| Fulgent Genetics | 469.01M |
| Prenetics Global | 300.05M |
| Burning Rock Biotech | 222.55M |
| Insight Molecular Diagnostics | 123.53M |
| FONAR | 123.25M |